MINERVA NEUROSCIENCES INC overview

Thinking about buying stock in Bright Minds Biosciences, Kiora Pharmaceuticals, FuelCell Energy, Athersys, or Minerva Neurosciences? PR Newswire NEW YORK, Aug. 25, 2022 NEW YORK , Aug. 25, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DRUG, KPRX, FCEL, ATHX, and NERV. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. DRUG:...

Thinking about buying stock in Scisparc, Tufin Software Technologies, Farfetch, Energy Transfer, or Minerva Neurosciences? PR Newswire NEW YORK, Aug. 24, 2022 NEW YORK , Aug. 24, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SPRC, TUFN, FTCH, ET, and NERV. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. SPRC:...

...

Thinking about buying stock in Minerva Neurosciences, Fubotv, Lucira Health, Biomerica, or Comstock Mining? PR Newswire NEW YORK, May 12, 2021 NEW YORK , May 12, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NERV, FUBO, LHDX, BMRA, and LODE. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. NERV:...

NERV INVESTOR DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc. PR Newswire NEW YORK, Dec. 24, 2020 NEW YORK , Dec. 24, 2020 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or...

NERV INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit has been Filed Against Minerva Neurosciences, Inc. PR Newswire NEW YORK, Dec. 10, 2020 NEW YORK , Dec. 10, 2020 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of Minerva Neurosciences, Inc. ("Minerva" or the "Company") (NASDAQ: NERV) from...

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Minerva Neurosciences, Inc. (NASDAQ: NERV) between May 15, 2017 to November 30, 2020, inclusive (the "Class Period"). The lawsuit seeks to recover damages for Minerva investors under the federal securities laws. To join the Minerva class action, go to http://www.rosenlegal.com/cases-register-2004.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or...

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of investors that purchased Minerva Neurosciences, Inc. (NASDAQ: NERV) common stock between May 5, 2017 and November 30, 2020 (the “Class Period”). Investors have until February 8, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Click here to...